No Stop Orders. No order preventing or suspending the use of the Base Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 43 contracts
Samples: Securities Purchase Agreement (Evogene Ltd.), Securities Purchase Agreement (Acurx Pharmaceuticals, Inc.), Securities Purchase Agreement (Lixte Biotechnology Holdings, Inc.)
No Stop Orders. No order preventing or suspending the use of the Base Registration Statement, the Preliminary Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 24 contracts
Samples: Securities Purchase Agreement (Shuttle Pharmaceuticals Holdings, Inc.), Securities Purchase Agreement (Qualigen Therapeutics, Inc.), Securities Purchase Agreement (CNS Pharmaceuticals, Inc.)
No Stop Orders. No order preventing or suspending the use of the U.S. Base Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 7 contracts
Samples: Securities Purchase Agreement (Very Good Food Co Inc.), Securities Purchase Agreement (FSD Pharma Inc.), Securities Purchase Agreement (FSD Pharma Inc.)
No Stop Orders. No order preventing or suspending the use of the Base Registration Statement, the Prospectus, the Prospectus Supplement, or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 2 contracts
Samples: Securities Purchase Agreement (OptiNose, Inc.), Securities Purchase Agreement (Vaccinex, Inc.)
No Stop Orders. No order preventing or suspending the use of the Base Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Verb Technology Company, Inc.), Securities Purchase Agreement (Tanzanian Gold Corp)
No Stop Orders. No order preventing or suspending the use of the either Base Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.), Securities Purchase Agreement (Tonix Pharmaceuticals Holding Corp.)
No Stop Orders. No order preventing or suspending the use of the Base Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission.
Appears in 1 contract
